Medicine: Capsules, Jul. 14, 1952

¶ In the A.M.A. Journal, three groups of doctors reported fatal cases (eight in all) of aplastic anemia following treatment with the antibiotic Chloromycetin. Editorially, the Journal warned against use of the drug for minor ills, wondered whether it might have to be limited to such serious complaints as typhoid. The Food & Drug Administration started checking all new cases of aplastic anemia to see whether Chloromycetin had been used.

¶Marsilid, one of the isoniazed* drugs now being widely tested against T.B., may be useful for a lot of other things, three New York City doctors reported in London. They found that...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!